These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30976939)

  • 1. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing and biomarkers for gastric cancer: what is the future?
    Kawazoe A; Shitara K
    Ther Adv Med Oncol; 2019; 11():1758835919848189. PubMed ID: 31258627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents on the horizon in gastric cancer.
    Lordick F; Shitara K; Janjigian YY
    Ann Oncol; 2017 Aug; 28(8):1767-1775. PubMed ID: 28184417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
    Corso S; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New targeted therapies for gastric cancer.
    Asaoka Y; Ikenoue T; Koike K
    Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
    Tirino G; Pompella L; Petrillo A; Laterza MM; Pappalardo A; Caterino M; Orditura M; Ciardiello F; Galizia G; De Vita F
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine in gastric cancer: Where are we and where are we going?
    Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
    World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into next developments in advanced gastric cancer.
    Obermannová R; Lordick F
    Curr Opin Oncol; 2016 Jul; 28(4):367-75. PubMed ID: 27092990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging therapies in unresectable and recurrent gastric cancer.
    Jou E; Rajdev L
    World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care.
    Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Companion diagnostics for the targeted therapy of gastric cancer.
    Yoo C; Park YS
    World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Choi YY; Cheong JH
    Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Park R; Williamson S; Kasi A; Saeed A
    Anticancer Res; 2018 Oct; 38(10):5569-5580. PubMed ID: 30275174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
    Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
    World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.
    Singh P; Toom S; Huang Y
    J Hematol Oncol; 2017 May; 10(1):105. PubMed ID: 28494772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future molecular testing of lung carcinoma.
    Dacic S; Nikiforova MN
    Adv Anat Pathol; 2014 Mar; 21(2):94-9. PubMed ID: 24508692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.